Day: February 21, 2023

Junshi Biosciences Announces Toripalimab in Combination with Chemotherapy for Treatment of Advanced Triple-negative Breast Cancer Met Primary Endpoint in Phase 3 Clinical Study

by

SHANGHAI, China, Feb. 20, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) today announced that the pre-specified interim analysis has been completed for a randomized, double-blind, placebo-controlled, multi-center phase III clinical study (“TORCHLIGHT Study”, NCT04085276) examining the company’s product toripalimab in combination with paclitaxel for injection (albumin-bound) in […]

Mizar announces its Much-Requested Token Generation Event (TGE)

by

$MZR LONDON, Feb. 20, 2023 (GLOBE NEWSWIRE) — Following the successful completion of seed and private rounds and 9 figures trading volumes on their copy trading platform, Mizar (MZR Inc) is excited to announce its upcoming Token Generation Event, on 9th March 2023. Since the open Beta release, Mizar has been striving to bring a […]